453 related articles for article (PubMed ID: 26196392)
21. Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo.
Cai X; Hu X; Cai B; Wang Q; Li Y; Tan X; Hu H; Chen X; Huang J; Cheng J; Jing X
Oncol Rep; 2013 Nov; 30(5):2449-57. PubMed ID: 24008375
[TBL] [Abstract][Full Text] [Related]
22. Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation.
Sikka A; Kaur M; Agarwal C; Deep G; Agarwal R
Cell Cycle; 2012 Apr; 11(7):1374-82. PubMed ID: 22421144
[TBL] [Abstract][Full Text] [Related]
23. Metformin suppresses the esophageal carcinogenesis in rats treated with NMBzA through inhibiting AMPK/mTOR signaling pathway.
Fan H; Yu X; Zou Z; Zheng W; Deng X; Guo L; Jiang W; Zhan Q; Lu SH
Carcinogenesis; 2019 Jul; 40(5):669-679. PubMed ID: 30445633
[TBL] [Abstract][Full Text] [Related]
24. Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth.
Rocha GZ; Dias MM; Ropelle ER; Osório-Costa F; Rossato FA; Vercesi AE; Saad MJ; Carvalheira JB
Clin Cancer Res; 2011 Jun; 17(12):3993-4005. PubMed ID: 21543517
[TBL] [Abstract][Full Text] [Related]
25. Metformin induces apoptosis and cell cycle arrest mediated by oxidative stress, AMPK and FOXO3a in MCF-7 breast cancer cells.
Queiroz EA; Puukila S; Eichler R; Sampaio SC; Forsyth HL; Lees SJ; Barbosa AM; Dekker RF; Fortes ZB; Khaper N
PLoS One; 2014; 9(5):e98207. PubMed ID: 24858012
[TBL] [Abstract][Full Text] [Related]
26. [The expression of p53, p16, cyclin D1 in esophageal squamous cell carcinoma and esophageal dysplasia].
Kim SG; Hong SJ; Kwon KW; Jung SW; Kim WY; Jung IS; Ko BM; Ryu CB; Kim YS; Moon JH; Kim JO; Cho JY; Lee JS; Lee MS; Shim CS; Kim BS
Korean J Gastroenterol; 2006 Oct; 48(4):269-76. PubMed ID: 17060721
[TBL] [Abstract][Full Text] [Related]
27. β-Cryptoxanthin induced anti-proliferation and apoptosis by G0/G1 arrest and AMPK signal inactivation in gastric cancer.
Gao M; Dang F; Deng C
Eur J Pharmacol; 2019 Sep; 859():172528. PubMed ID: 31288004
[TBL] [Abstract][Full Text] [Related]
28. Role of AMPK signaling in mediating the anticancer effects of silibinin in esophageal squamous cell carcinoma.
Li J; Li B; Xu WW; Chan KW; Guan XY; Qin YR; Lee NP; Chan KT; Law S; Tsao SW; Cheung AL
Expert Opin Ther Targets; 2016; 20(1):7-18. PubMed ID: 26568207
[TBL] [Abstract][Full Text] [Related]
29. Antidiabetic drug metformin inhibits esophageal adenocarcinoma cell proliferation in vitro and in vivo.
Fujihara S; Kato K; Morishita A; Iwama H; Nishioka T; Chiyo T; Nishiyama N; Miyoshi H; Kobayashi M; Kobara H; Mori H; Okano K; Suzuki Y; Masaki T
Int J Oncol; 2015 May; 46(5):2172-80. PubMed ID: 25709052
[TBL] [Abstract][Full Text] [Related]
30. Antitumor effect of metformin in esophageal cancer: in vitro study.
Kobayashi M; Kato K; Iwama H; Fujihara S; Nishiyama N; Mimura S; Toyota Y; Nomura T; Nomura K; Tani J; Miyoshi H; Kobara H; Mori H; Murao K; Masaki T
Int J Oncol; 2013 Feb; 42(2):517-24. PubMed ID: 23229592
[TBL] [Abstract][Full Text] [Related]
31. Protocatechuic acid inhibits oleic acid-induced vascular smooth muscle cell proliferation through activation of AMP-activated protein kinase and cell cycle arrest in G0/G1 phase.
Lin MC; Ou TT; Chang CH; Chan KC; Wang CJ
J Agric Food Chem; 2015 Jan; 63(1):235-41. PubMed ID: 25513741
[TBL] [Abstract][Full Text] [Related]
32. Isoalantolactone Inhibits Esophageal Squamous Cell Carcinoma Growth Through Downregulation of MicroRNA-21 and Derepression of PDCD4.
Wen SW; Zhang YF; Li Y; Xu YZ; Li ZH; Lü H; Zhu YG; Liu ZX; Tian ZQ
Dig Dis Sci; 2018 Sep; 63(9):2285-2293. PubMed ID: 29781054
[TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma.
Luo Q; Hu D; Hu S; Yan M; Sun Z; Chen F
BMC Cancer; 2012 Nov; 12():517. PubMed ID: 23151022
[TBL] [Abstract][Full Text] [Related]
34. Nutlin-3, an Antagonist of MDM2, Enhances the Radiosensitivity of Esophageal Squamous Cancer with Wild-Type p53.
He T; Guo J; Song H; Zhu H; Di X; Min H; Wang Y; Chen G; Dai W; Ma J; Sun X; Ma J
Pathol Oncol Res; 2018 Jan; 24(1):75-81. PubMed ID: 28341911
[TBL] [Abstract][Full Text] [Related]
35. Study of the antitumor mechanisms of apiole derivatives (AP-02) from Petroselinum crispum through induction of G0/G1 phase cell cycle arrest in human COLO 205 cancer cells.
Wu KH; Lee WJ; Cheng TC; Chang HW; Chen LC; Chen CC; Lien HM; Lin TN; Ho YS
BMC Complement Altern Med; 2019 Jul; 19(1):188. PubMed ID: 31351461
[TBL] [Abstract][Full Text] [Related]
36. RhBMP-2 Activates Hippo Signaling through RASSF1 in Esophageal Cancer Cells.
Kim SM; Ye S; Rah SY; Park BH; Wang H; Kim JR; Kim SH; Jang KY; Lee KB
Sci Rep; 2016 May; 6():26821. PubMed ID: 27230238
[TBL] [Abstract][Full Text] [Related]
37. Metformin inhibits esophagus cancer proliferation through upregulation of USP7.
Xu Y; Lu S
Cell Physiol Biochem; 2013; 32(5):1178-86. PubMed ID: 24335168
[TBL] [Abstract][Full Text] [Related]
38. Anticancer effects of suberoylanilide hydroxamic acid in esophageal squamous cancer cells in vitro and in vivo.
Tzao C; Jin JS; Chen BH; Chung HY; Chang CC; Hsu TY; Sun GH
Dis Esophagus; 2014; 27(7):693-702. PubMed ID: 24033428
[TBL] [Abstract][Full Text] [Related]
39. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
Li A; Wang J; Wu M; Zhang X; Zhang H
Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
[TBL] [Abstract][Full Text] [Related]
40. 3,3'-Diindolylmethane suppresses growth of human esophageal squamous cancer cells by G1 cell cycle arrest.
Kim SJ; Lee JS; Kim SM
Oncol Rep; 2012 May; 27(5):1669-73. PubMed ID: 22293900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
